---
title: "CRO/CMO concept experiences a volatile surge, ChemPartner hits the \"20cm\" limit up"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/250519558.md"
description: "The concept of CRO/CMO has experienced a volatile surge, with ChemPartner hitting the \"20cm\" limit up, followed by gains in PHARMABLOCK, HITECK, Jiuzhou Pharma, Tigermed, JOINN, and Nossan"
datetime: "2025-07-29T05:34:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/250519558.md)
  - [en](https://longbridge.com/en/news/250519558.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/250519558.md)
generator: "portal-rs"
---

# CRO/CMO concept experiences a volatile surge, ChemPartner hits the "20cm" limit up

The concept of CRO/CMO has fluctuated and surged, with ChemPartner hitting the "20cm" limit up, followed by gains in PHARMABLOCK, HITECK, Jiuzhou Pharma, Tigermed, JOINN, and Nossan

### Related Stocks

- [603456.CN](https://longbridge.com/en/quote/603456.CN.md)
- [300347.CN](https://longbridge.com/en/quote/300347.CN.md)
- [03347.HK](https://longbridge.com/en/quote/03347.HK.md)
- [603127.CN](https://longbridge.com/en/quote/603127.CN.md)
- [06127.HK](https://longbridge.com/en/quote/06127.HK.md)
- [300149.CN](https://longbridge.com/en/quote/300149.CN.md)
- [300725.CN](https://longbridge.com/en/quote/300725.CN.md)
- [300683.CN](https://longbridge.com/en/quote/300683.CN.md)

## Related News & Research

- [Livzon Pharma buys 3.5% Xinbeijiang Pharma stake for RMB 106.7 million](https://longbridge.com/en/news/296601614.md)
- [Promise Analyzes Telehealth Licensing Rules as Compact Hits Record 3,633 Licenses in a Month](https://longbridge.com/en/news/296635882.md)
- [Big Pharma Split declares August Class A distribution of $0.1 a share](https://longbridge.com/en/news/296780591.md)
- [Guotai Asset Management says China innovative drug selloff is trading-driven, fundamentals intact](https://longbridge.com/en/news/296770934.md)
- [Innova Captab Revises FY26 Accounts and Clears Baddi Plant Expansion](https://longbridge.com/en/news/296661728.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**